Although initial clinical studies have consistently shown remarkable therapeutic efficacy of CTLA-4 inhibitors in patients with MM, Patients with advanced mucosal melanoma who had failed nivolumab therapy [104,155]. Here, CTLA4 is linked to Miyoshi myopathy.